Cargando…
Serum NT-pro-BNP Levels Predict Cardiovascular Events in Acromegaly Patients
Background Acromegaly is associated with an increased risk of fatal and non-fatal cardiovascular (CV) events. Controlling acromegaly decreases, but does not normalize this risk. Brain natriuretic peptide (BNP) assessment is used in the general population for the diagnosis of heart failure and to pre...
Autores principales: | Ragonese, Marta, Di Bella, Gianluca, Spagnolo, Federica, Grasso, Loredana, Alibrandi, Angela, Giuffrida, Guiseppe, Moleti, Mariacarla, Ferraù, Francesco, Cannavò, Salvatore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072124/ https://www.ncbi.nlm.nih.gov/pubmed/34942671 http://dx.doi.org/10.1055/a-1540-5009 |
Ejemplares similares
-
Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide
por: Puglisi, Soraya, et al.
Publicado: (2020) -
Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023) -
Epidemiology, course, and outcomes of Sars-CoV-2 infection in patients with acromegaly and Cushing’s disease: a monocentric experience in Southern Italy
por: Ragonese, M., et al.
Publicado: (2023) -
Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
por: Curiati, Milena Novaes Cardoso, et al.
Publicado: (2013) -
Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010)